Literature DB >> 24900049

A Patient with Psoriatic Arthritis Imaged with FDG-PET/CT Demonstrated an Unusual Imaging Pattern with Muscle and Fascia Involvement: A Case Report.

Sukhkarn Bains1, Matthew Reimert2, Aung Zaw Win3, Sana Khan1, Carina Mari Aparici4.   

Abstract

We describe the case of a patient with known history of psoriasis that presented with 1 year of unexplained fever, muscle weakness and marked weight loss, suspicious for B symptoms of a malignant origin. [(18)F]-Fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) scans demonstrated an unusual serpiginous pattern of uptake in the fascia and muscles as well as lymph node activity. Multiple histological samples, including a final PET-probe guided lymph node surgical resection, excluded malignancy and confirmed the diagnosis of reactive inflammatory changes, with a plausible diagnosis of autoimmune lymphoproliferative syndrome with associated lymphadenitis, fasciitis and myositis, possibly mediated by tumor necrosis factor (TNF) inhibitor. To our knowledge, there is no evidence of a previously reported FDG uptake pattern of fascia and muscle involvement in psoriatic arthritis.

Entities:  

Keywords:  Autoimmune; Autoimmune lymphoproliferative syndrome; FDG-PET/CT; Psoriasis

Year:  2012        PMID: 24900049      PMCID: PMC4042994          DOI: 10.1007/s13139-012-0137-9

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  11 in total

1.  Proliferative myositis in a child.

Authors:  S Mulier; M Stas; J Delabie; L Lateur; M Gysen; P Dal Cin; C Robberecht; I De Wever
Journal:  Skeletal Radiol       Date:  1999-12       Impact factor: 2.199

2.  FDG PET/CT findings in a case of myositis ossificans circumscripta of the forearm.

Authors:  Frédéric Clarençon; Frédérique Larousserie; Antoine Babinet; Christophe Zylbersztein; Jean-Noël Talbot; Khaldoun Kerrou
Journal:  Clin Nucl Med       Date:  2011-01       Impact factor: 7.794

3.  Incidental finding of F-18 FDG skin uptake in a patient with psoriasis during the evaluation of a recurrent papillary thyroid carcinoma.

Authors:  Claire Bruna-Muraille; Jean-Marie Pochart; Dimitri Papathanassiou; Renaud Guedec-Ghelfi; Amélie Cuif-Job; Jean-Claude Liehn
Journal:  Clin Nucl Med       Date:  2011-01       Impact factor: 7.794

4.  Non-Hodgkin's lymphoma of the bone and the liver without lymphadenopathy revealed on FDG-PET/CT.

Authors:  Gang Cheng; Sabah Servaes; Wichana Chamroonrat; Jianing Li; Hongming Zhuang
Journal:  Clin Imaging       Date:  2010 Nov-Dec       Impact factor: 1.605

5.  Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic.

Authors:  David A Wetter; Mark D P Davis
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

6.  Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Authors:  Nehal N Mehta; YiDing Yu; Babak Saboury; Negar Foroughi; Parasuram Krishnamoorthy; Anna Raper; Amanda Baer; Jules Antigua; Abby S Van Voorhees; Drew A Torigian; Abass Alavi; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2011-05-16

Review 7.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

Review 8.  Psoriasis and metabolic disease: epidemiology and pathophysiology.

Authors:  Rahat S Azfar; Joel M Gelfand
Journal:  Curr Opin Rheumatol       Date:  2008-07       Impact factor: 5.006

9.  The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.

Authors:  Shanu Kohli Kurd; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

10.  Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.

Authors:  Stephen M Broski; Wessam Bou-Assaly; Milton D Gross; Lorraine M Fig
Journal:  Clin Nucl Med       Date:  2009-04       Impact factor: 7.794

View more
  6 in total

Review 1.  Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents.

Authors:  Thomas Ebenhan; Janke Kleynhans; Jan Rijn Zeevaart; Jae Min Jeong; Mike Sathekge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-12       Impact factor: 9.236

2.  Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Chadwick L Wright; Edward W Martin
Journal:  BMC Cancer       Date:  2015-05-08       Impact factor: 4.430

Review 3.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

Review 4.  Diagnosis and Intervention in Early Psoriatic Arthritis.

Authors:  Tomoyuki Hioki; Mayumi Komine; Mamitaro Ohtsuki
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

5.  18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.

Authors:  Stephen P Povoski; Douglas A Murrey; Sabrina M Smith; Edward W Martin; Nathan C Hall
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

6.  Comparison of two threshold detection criteria methodologies for determination of probe positivity for intraoperative in situ identification of presumed abnormal 18F-FDG-avid tissue sites during radioguided oncologic surgery.

Authors:  Gregg J Chapman; Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Robert Lee; Edward W Martin
Journal:  BMC Cancer       Date:  2014-09-13       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.